Get started
Author

G. Denise Zielinski

Observed names: G D Zielinski, G Denise Zielinski, G. D. Zielinski, G.D. Zielinski, G.Denise Zielinski, Gilda D Zielinski, Gilda D. Zielinski, Gilda Denise Zielinski, Zielinski, G.D., Zielinski, Gilda Denise
ORCID: 0000-0003-1046-4055
Observed ORCID: 0000-0003-1046-4055
OpenAlex ID: A5041607203
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
2005 · S Bulk, J Berkhof, et al. · British Journal of Cancer · 163
PDF
The presence of high‐risk HPV combined with specific p53 and p16 INK4a expression patterns points to high‐risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix
2003 · G Denise Zielinski, Peter JF Snijders, et al. · The Journal of Pathology · 149
HPV Testing and Monitoring of Women After Treatment of CIN 3: Review of the Literature and Meta-analysis
2004 · G.D. Zielinski, A.G. Bais, et al. · Obstetrical & Gynecological Survey · 145
HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears
2001 · G D Zielinski, P J F Snijders, et al. · British Journal of Cancer · 118
PDF
High‐risk HPV testing in women with borderline and mild dyskaryosis: long‐term follow‐up data and clinical relevance
2001 · G. Denise Zielinski, Peter J. F. Snijders, et al. · The Journal of Pathology · 79
HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3
2003 · G.Denise Zielinski, Lawrence Rozendaal, et al. · Gynecologic Oncology · 76
Evaluation of cervical screening strategies with adjunct high‐risk human papillomavirus testing for women with borderline or mild dyskaryosis
2005 · Johannes Berkhof, Martine C. de Bruijne, et al. · International Journal of Cancer · 50
Clinical relevance of human papillomavirus testing in cytopathology
2005 · A. A. T. P. Brink, G. D. Zielinski, et al. · Cytopathology · 43
Natural history and screening model for high‐risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands
2005 · Johannes Berkhof, Martine C de Bruijne, et al. · International Journal of Cancer · 42
Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
2019 · Gilda Denise Zielinski, Nienke van Rein, et al. · Research and Practice in Thrombosis and Haemostasis · 32
PDF
Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
2021 · Gilda D. Zielinski, Nienke van Rein, et al. · Pharmacoepidemiology and Drug Safety · 17
PDF
High-risk human papillomavirus is present in cytologically false-negative smears: an analysis of “normal” smears preceding CIN2/3
2007 · S Bulk, L Rozendaal, et al. · Journal of Clinical Pathology · 15
Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints
2018 · G. Denise Zielinski, Martina Teichert, et al. · Pharmacoepidemiology and Drug Safety · 3
[Condylomata acuminata: a rare symptom of ubiquitous human papilloma virus and not a sign of risky sex behavior].
1999 · G D Zielinski, A Knuistingh Neven, et al. · PubMed · 2
Temporal Trends in Patient Characteristics, Anticoagulation Treatment Quality, and Clinical Outcomes of Individuals Receiving Vitamin K Antagonists in the Netherlands (2014 Until–2022)
2026 · Gilda D. Zielinski, Qingui Chen, et al. · Pharmacoepidemiology and Drug Safety
PDF
Therapietrouw van patiënten met atriumfibrilleren voor direct werkende orale anticoagulantia
2020 · Zielinski, Gilda Denise, van Rein, Nienke, et al. · Data Archiving and Networked Services (DANS)
Works count: 17
Citation count: 934
H-index: 12
I10-index: 12
Year
Topic
Type